European regulator proposal would ‘streamline’ biosimilar processnews2025-04-01T17:23:14+00:00April 1st, 2025|Endpoints News|
Sanofi continues its bet on R&D by poaching GSK’s head of developmentnews2025-04-01T10:40:23+00:00April 1st, 2025|Endpoints News|
J&J’s third talc bankruptcy bid is stopped by Texas federal judge news2025-03-31T23:31:56+00:00March 31st, 2025|Endpoints News|
Federal judge nixes FDA’s lab-developed test rulenews2025-03-31T21:20:15+00:00March 31st, 2025|Endpoints News|
DC court sides with HHS in Vertex’s fertility program fightnews2025-03-31T19:57:10+00:00March 31st, 2025|Endpoints News|
Merck’s PAH drug slashed risk of serious events in halted trialnews2025-03-31T16:23:43+00:00March 31st, 2025|Endpoints News|
Amgen loses challenge to Colorado drug review boardnews2025-03-28T19:35:47+00:00March 28th, 2025|Endpoints News|
J&J wins patent feud against Viatris over schizophrenia drugnews2025-03-28T17:05:43+00:00March 28th, 2025|Endpoints News|
CHMP acts on Opdivo, Tevimbra, Xoanacyl, Kisunla and othersnews2025-03-28T16:20:49+00:00March 28th, 2025|Endpoints News|
